earnings
confidence high
sentiment negative
materiality 0.65
SelectQuote corrects FY2023 net loss guidance upward; previously understated
SelectQuote, Inc.
2023-Q3 EPS reported
-$0.06
revenue$781,070,000
- Corrected FY2023 net loss guidance now $73M-$55M (previously understated).
- Q3 FY2023 revenue $299.4M, net income $9.3M, Adjusted EBITDA $44.0M.
- Senior segment revenue $185.2M, Adjusted EBITDA $59.2M on 165,530 approved Medicare Advantage policies.
- Healthcare Services revenue $70.7M, Adjusted EBITDA loss $3.4M; SelectRx members ~45,000.
- FY2023 guidance: revenue $950M-$970M, Adjusted EBITDA $40M-$50M.